Stocks and Investing Stocks and Investing
Mon, May 6, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Gary Prestopino Maintained (ACVA) at Buy and Held Target at $23 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
James Thalacker Maintained (AEE) at Buy with Increased Target to $81 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $33 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Emmanuel Rosner Maintained (ADNT) at Hold with Decreased Target to $30 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Joseph Spak Maintained (ADNT) at Hold with Decreased Target to $31 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Douglas Tsao Reiterated (aeon) at Strong Buy and Held Target at $18 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Atif Malik Maintained (AEIS) at Strong Buy with Increased Target to $113 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Paul Newsome Maintained (AFG) at Hold with Increased Target to $135 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Stephen Trent Maintained (AER) at Strong Buy with Increased Target to $103 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Brent Thielman Maintained (ACA) at Strong Buy with Increased Target to $105 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Jay Olson Maintained (ACAD) at Hold and Held Target at $19 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Jay McCanless Reiterated (ABR) at Hold and Held Target at $13 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Steve Sakwa Maintained (BXP) at Buy with Decreased Target to $69 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Sarang Vora Reiterated (BRCC) at Buy and Held Target at $8 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Stephen Gengaro Maintained (BOOM) at Strong Buy with Decreased Target to $24 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Terence Flynn Maintained (BPMC) at Strong Buy with Increased Target to $168 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Andrew Berens Upgraded (BPMC) to Hold and Increased Target to $97 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Stephen Baxter Maintained (btsg) at Buy with Increased Target to $16 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Dan Levy Maintained (BWA) at Buy with Increased Target to $45 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Itay Michaeli Maintained (BWA) at Hold with Increased Target to $41 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Alex Straton Maintained (BURL) at Buy with Decreased Target to $218 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Arun Viswanathan Maintained (ALB) at Buy with Increased Target to $157 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Ben Isaacson Maintained (ALB) at Buy with Decreased Target to $150 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Tim Moore Maintained (ALG) at Strong Buy and Held Target at $270 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Francois Brisebois Reiterated (ALDX) at Buy and Held Target at $10 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Matthew Caufield Reiterated (ALDX) at Strong Buy and Held Target at $10 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Alexandra Steiger Maintained (ANF) at Hold with Increased Target to $112 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Kevin Heal Maintained (AMP) at Strong Buy with Increased Target to $460 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Les Sulewski Reiterated (AMRX) at Strong Buy with Increased Target to $9 on, May 6th, 2024
[ Mon, May 06th 2024 ] - WOPRAI
Nathan Rich Maintained (AMRX) at Strong Buy with Increased Target to $8 on, May 6th, 2024

Nathan Rich Maintained (AMRX) at Strong Buy with Increased Target to $8 on, May 6th, 2024


Published on 2024-10-28 11:00:36 - WOPRAI, Nathan Rich
  Print publication without navigation


Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $6.25 to $8 on, May 6th, 2024.

Nathan has made no other calls on AMRX in the last 4 months.



There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Nathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Nathan

  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $8 on, Thursday, March 21st, 2024
  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $8 on, Monday, January 29th, 2024
Contributing Sources